Page 1 | Search Results | Hematology, ASH Education Program

1-17 of 17

Sort by

Sort Order Select

Journal Articles

What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

Alessandro M. Vannucchi, Paola Guglielmelli

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 480–488.

https://doi.org/10.1182/asheducation-2017.1.480

Published: 2017

Journal Articles

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Holly L. Geyer, Ruben A. Mesa

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 277–286.

https://doi.org/10.1182/asheducation-2014.1.277

Published: 2014

Journal Articles

Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia

Nicole Aqui, Una O'Doherty

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 457–460.

https://doi.org/10.1182/asheducation-2014.1.457

Published: 2014

Journal Articles

Established and novel agents for myelodysplastic syndromes

Mikkael A. Sekeres, Aaron T. Gerds

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 82–89.

https://doi.org/10.1182/asheducation-2014.1.82

Published: 2014

Journal Articles

Does hematopoietic stem cell transplantation benefit infants with acute leukemia?

Edward Allan R. Sison, Patrick Brown

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 601–604.

https://doi.org/10.1182/asheducation-2013.1.601

Published: 2013

Journal Articles

Beyond JAK inhibitor therapy in myelofibrosis

Olatoyosi Odenike

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 545–552.

https://doi.org/10.1182/asheducation-2013.1.545

Published: 2013

Journal Articles

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?

Jay P. Patel, Ross L. Levine

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 28–34.

https://doi.org/10.1182/asheducation.V2012.1.28.3797923

Published: 2012

Journal Articles

Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies

David L. Porter

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 292–298.

https://doi.org/10.1182/asheducation-2011.1.292

Published: 2011

Journal Articles

Pediatric Acute Leukemia Therapies Informed by Molecular Analysis of High-Risk Disease

Stuart S. Winter

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 366–373.

https://doi.org/10.1182/asheducation-2011.1.366

Published: 2011

Journal Articles

Management of Essential Thrombocythemia

Francisco Cervantes

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 215–221.

https://doi.org/10.1182/asheducation-2011.1.215

Published: 2011

Journal Articles

The Genetic Basis of Myeloproliferative Disorders

Radek Skoda

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 1–10.

https://doi.org/10.1182/asheducation-2007.1.1

Published: 2007

Journal Articles

Double Hazard of Thrombophilia and Bleeding in Leukemia

Hau C. Kwaan

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 151–157.

https://doi.org/10.1182/asheducation-2007.1.151

Published: 2007

Journal Articles

Navigating the Evolving Paradigms in the Diagnosis and Treatment of Myeloproliferative Disorders

Ruben A. Mesa

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 355–362.

https://doi.org/10.1182/asheducation-2007.1.355

Published: 2007

Journal Articles

Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies

Anna Falanga, Frederick R. Rickles

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 165–171.

https://doi.org/10.1182/asheducation-2007.1.165

Published: 2007

Journal Articles

Coagulation in the Pathophysiology of Hemolytic Anemias

Maria Domenica Cappellini

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 74–78.

https://doi.org/10.1182/asheducation-2007.1.74

Published: 2007

Journal Articles

Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis

Zhen-yi Wang, MD

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 1–13.

https://doi.org/10.1182/asheducation.V2003.1.1.1

Published: 2003

Journal Articles

A Polycythemia Vera Update: Diagnosis, Pathobiology, and Treatment

Thomas C. Pearson, Maria Messinezy, Nigel Westwood, Anthony R. Green, Anthony J. Bench, Anthony R. Green, Brian J.P. Huntly, Elizabeth P. Nacheva, Tiziano Barbui, Guido Finazzi

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 51–68.

https://doi.org/10.1182/asheducation.V2000.1.51.51

Published: 2000

NARROW

What are the current treatment approaches for patients with polycythemia vera and essential thrombocythemia?

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Leukocytapheresis for the treatment of hyperleukocytosis secondary to acute leukemia

Established and novel agents for myelodysplastic syndromes

Does hematopoietic stem cell transplantation benefit infants with acute leukemia?

Beyond JAK inhibitor therapy in myelofibrosis

How do novel molecular genetic markers influence treatment decisions in acute myeloid leukemia?

Allogeneic Immunotherapy to Optimize the Graft-versus-Tumor Effect: Concepts and Controversies

Pediatric Acute Leukemia Therapies Informed by Molecular Analysis of High-Risk Disease

Management of Essential Thrombocythemia

The Genetic Basis of Myeloproliferative Disorders

Double Hazard of Thrombophilia and Bleeding in Leukemia

Navigating the Evolving Paradigms in the Diagnosis and Treatment of Myeloproliferative Disorders

Management of Thrombohemorrhagic Syndromes (THS) in Hematologic Malignancies

Coagulation in the Pathophysiology of Hemolytic Anemias

Ham-Wasserman Lecture: Treatment of Acute Leukemia by Inducing Differentiation and Apoptosis

A Polycythemia Vera Update: Diagnosis, Pathobiology, and Treatment

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only